001     120012
005     20240228135007.0
024 7 _ |a 10.1128/MCB.00766-14
|2 doi
024 7 _ |a pmid:25225333
|2 pmid
024 7 _ |a pmc:PMC4248750
|2 pmc
024 7 _ |a 0270-7306
|2 ISSN
024 7 _ |a 1098-5549
|2 ISSN
037 _ _ |a DKFZ-2017-00600
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Fischer-Kešo, Regina
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins.
260 _ _ |a Washington, DC
|c 2014
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1490697550_15175
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Plakophilins 1 and 3 (PKP1/3) are members of the arm repeat family of catenin proteins and serve as structural components of desmosomes, which are important for cell-cell-adhesion. In addition, PKP1/3 occur as soluble proteins outside desmosomes, yet their role in the cytoplasm is not known. We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs. Moreover, we showed that the interaction of PKP1/3 with G3BP, PABPC1, and UPF1 but not with FXR1 was RNase sensitive. To address the cytoplasmic function of PKP1/3, we performed gain-and-loss-of-function studies. Both PKP1 and PKP3 knockdown cell lines showed reduced protein and mRNA levels for desmoplakin and PKP2. Whereas global rates of translation were unaffected, desmoplakin and PKP2 mRNA were destabilized. Furthermore, binding of PKP1/3 to FXR1 was RNA independent, and both PKP3 and FXR1 stabilized PKP2 mRNA. Our results demonstrate that cytoplasmic PKP1/3 are components of mRNA ribonucleoprotein particles and act as posttranscriptional regulators of gene expression.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Carrier Proteins
|2 NLM Chemicals
650 _ 7 |a Desmoplakins
|2 NLM Chemicals
650 _ 7 |a FXR1 protein, human
|2 NLM Chemicals
650 _ 7 |a G3BP protein, human
|2 NLM Chemicals
650 _ 7 |a PABPC1L protein, human
|2 NLM Chemicals
650 _ 7 |a PKP1 protein, human
|2 NLM Chemicals
650 _ 7 |a PKP3 protein, human
|2 NLM Chemicals
650 _ 7 |a Plakophilins
|2 NLM Chemicals
650 _ 7 |a Poly(A)-Binding Proteins
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a RNA-Binding Proteins
|2 NLM Chemicals
650 _ 7 |a Trans-Activators
|2 NLM Chemicals
650 _ 7 |a UPF1 protein, human
|2 NLM Chemicals
700 1 _ |a Breuninger, Sonja
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hofmann, Sarah
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Henn, Manuela
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Röhrig, Theresa
|b 4
700 1 _ |a Ströbel, Philipp
|b 5
700 1 _ |a Stoecklin, Georg
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Hofmann, Ilse
|0 P:(DE-He78)0c4543046185361a644540fee0dad8b1
|b 7
|e Last author
|u dkfz
773 _ _ |a 10.1128/MCB.00766-14
|g Vol. 34, no. 23, p. 4244 - 4256
|0 PERI:(DE-600)1474919-1
|n 23
|p 4244 - 4256
|t Molecular and cellular biology
|v 34
|y 2014
|x 1098-5549
909 C O |o oai:inrepo02.dkfz.de:120012
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)0c4543046185361a644540fee0dad8b1
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL CELL BIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l Vaskuläre Onkologie und Metastasierung
|x 0
920 1 _ |0 I:(DE-He78)A200-20160331
|k A200
|l Posttranskriptionelle Genregulation
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a I:(DE-He78)A200-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21